| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| 2903780000 |
|
|
|
| USP-1525999 |
Phenoxybenzamine Alcohol (需冷链运输) (50 mg) (2-[Benzyl(1-phenoxypropan-2-yl)amino]ethan-1-ol) |
101-45-1 |
|
| 2922504500 |
|
|
|
| USP-1526200 |
Phenoxyethanol (500 mg) (2-Phenoxyethanol) |
122-99-6 |
|
| 2909490000 |
|
|
|
| USP-1528534 |
Phentermine Related Compound C (100 mg) ((2-Methylprop-1-en-1-yl)benzene) |
768-49-0 |
UN3295 |
| USP-1533250 |
Phenylethyl Alcohol (1 mL) |
1960/12/8 |
UN2810 |
| USP-1535802 |
Phosphoric Acid (1.5 mL/ampule; 3 ampules) |
7664-38-2 |
UN1805 |
| USP-1537910 |
Phytic Acid Solution (5 mL) |
83-86-3 |
UN3265 |
| USP-1538006 |
Phytonadione (100 mg x 5 ampules) (Vitamin K1) |
81818-54-4 |
|
| 2936299055 |
|
|
|
| USP-1544428 |
Piroctone Related Compound B (25 mg) (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one) |
50650-75-4 |
|
| 2932999000 |
|
|
|
| USP-1545056 |
Plastic Additive 14 (100 mg) (Di(2-ethylhexyl) phthalate) |
117-81-7 |
UN3082 |
| USP-1545067 |
Plastic Additive 15 (100 mg) (Epoxidized Soya Oil) |
8013/7/8 |
UN3082 |
| USP-1545078 |
Plastic Additive 16 (100 mg) (Epoxidized Linseed Oil) |
8016/11/3 |
|
| 1518000000 |
|
|
|
| USP-1546150 |
Poloxamer Liquid (1 mL) |
9003/11/6 |
|
| 3402491000 |
|
|
|
| USP-1546300 |
Polydimethylsiloxane (500 mg) |
9016-00-6 |
|
| 3910000000 |
|
|
|
| USP-1546401 |
Polyethylene Glycol 200 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1546445 |
Polyethylene Glycol 400 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1546467 |
Polyethylene Glycol 600 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1546944 |
Polyglyceryl 3 Diisostearate (1 mL) |
63705-03-3 |
|
| 3907290000 |
|
|
|
| USP-1547200 |
Polyoxyl 35 Castor Oil (1 g) |
61791-12-6 |
|
| 3913908000 |
|
|
|
| USP-1547302 |
Polyoxyl 10 Oleyl Ether (1 mL) |
9004-98-2 |
|
| 3402491000 |
|
|
|
| USP-1547925 |
Polysorbate 20 (2 g) |
9005-64-5 |
|
| 3402421000 |
|
|
|
| USP-1547969 |
Polysorbate 80 (4 x 0.5 g) |
9005-65-6 |
|
| 3402421000 |
|
|
|
| USP-1547991 |
Polypropylene Glycol 11 Stearyl Ether (500 mg) |
25231-21-4 |
|
| 3907290000 |
|
|
|
| USP-1548043 |
Polyvinyl Acetate Dispersion (1 g) (Polyvinyl Acetate stabilized with Povidone and Sodium Lauryl Sulfate) |
9003-20-7 |
|
| 3905210000 |
|
|
|
| USP-1559709 |
Prekallikrein Activator (22.5 IU) |
N/A |
|
| 3502900000 |
|
|
|
| USP-1570406 |
1-Propanol (1.2 mL/ampule; 3 ampules) |
71-23-8 |
UN1274 |
| USP-1570428 |
2-Propanol (1.2 mL/ampule; 3 ampules) |
67-63-0 |
UN1219 |
| USP-1570439 |
2-Propanol System Suitability (3 x 1 mL) |
N/A |
UN1219 |
| USP-1570450 |
Propanolamine (100 mg) (3-aminopropan-1-ol) |
156-87-6 |
UN2735 |
| USP-1570483 |
1,3-Propanediol (1 mL) |
504-63-2 |
|
| 2905390000 |
|
|
|
| USP-1572503 |
Propofol (500 mg) |
2078-54-8 |
|
| 2907199000 |
|
|
|
| USP-1572525 |
Propofol Resolution Mixture (100 mg) (Propofol, 2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1572547 |
Propofol Related Compound B (30 mg) (2,6-Diisopropyl-1,4-benzoquinone) |
1988-11-0 |
|
| 2914699000 |
|
|
|
| USP-1572558 |
Propofol Related Compound C (25 mg) (2,6-diisopropylphenyl isopropyl ether) |
N/A |
|
| 2909300000 |
|
|
|
| USP-1576402 |
Propyl Acetate (1.2 mL/ampule; 3 ampules) |
109-60-4 |
UN1276 |
| USP-1576661 |
Propylene Glycol Mono And Dicaprylate (1 g) |
85883-73-4 |
|
| 2915900000 |
|
|
|
| USP-1576672 |
Propylene Glycol Monocaprylate (1 g) (Propylene Glycol Monocaprylate Type II) |
N/A |
|
| 3824994100 |
|
|
|
| USP-1576683 |
Propylene Glycol Dicaprylate/Dicaprate (1 mL) |
68583-51-7 |
|
| 3824994100 |
|
|
|
| USP-1576708 |
Propylene Glycol (5 x 1 mL) |
57-55-6 |
|
| 2905320000 |
|
|
|
| USP-1576720 |
Propylene Glycol Diacetate (2 x 1 g) |
623-84-7 |
|
| 2915399500 |
|
|
|
| USP-1576763 |
Propylene Glycol Dilaurate (500 mg) |
22788-19-8 |
|
| 2915900000 |
|
|
|
| USP-1576785 |
Propylene Glycol Monolaurate Type I (500 mg) |
27194-74-7; 142-55-2 |
|
| 3824994100 |
|
|
|
| USP-1576796 |
Propylene Glycol Monolaurate Type II (500 mg) |
37321-62-3 |
|
| 3824994100 |
|
|
|
| USP-1576945 |
Propylene Oxide (5 x 0.1 mL) |
75-56-9 |
UN1280 |
| USP-1581617 |
Pseudoisoeugenyl 2-Methylbutyrate (4 x 50 mg) ((E)-4-Methoxy-2-(prop-1-en-1-yl)phenyl 2-methylbutanoate) |
58989-20-1 |
|
| 2918300000 |
|
|
|
| USP-1585028 |
Pyrazinamide Related Compound B (50 mg) (Pyrazinecarbonitrile) |
19847-12-2 |
|
| USP-1252003 |
Estradiol Cypionate (200 mg) |
313-06-4 |
|
| 2937230000 |
|
|
|
| USP-1252193 |
Estradiol Cypionate System Suitability Mixture (10 mg) (This mixture contains estradiol cypionate, estradiol-9-ene cypionate, estradiol dicypionate, and 4-methylestradiol cypionate) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1254009 |
Estradiol Valerate (100 mg) |
979-32-8 |
|
| 2937230000 |
|
|
|
| USP-1254031 |
Estradiol Valerate Identification Mixture (15 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1254508 |
Estriol (100 mg) |
50-27-1 |
|
| 2937230000 |
|
|
|
| USP-1255001 |
Estrone (200 mg) |
53-16-7 |
|
| 2937230000 |
|
|
|
| USP-1255500 |
Estropipate (500 mg) |
7280-37-7 |
|
| 2937230000 |
|
|
|
| USP-1255861 |
Eszopiclone Related Compound A (10 mg) (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide) |
43200-96-0 |
|
| 2933790002 |
|
|
|
| USP-1256004 |
Ethacrynic Acid (200 mg) |
58-54-8 |
|
| 2918992090 |
|
|
|
| USP-1256015 |
Ethacrynic Acid Related Compound A (25 mg) ((4-Butyryl-2,3-dichlorophenoxy)acetic acid) |
1217-67-0 |
|
| 2918992090 |
|
|
|
| USP-1256037 |
Ethacrynic Acid Related Compound C (25 mg) ({4-[2-(4-(Carboxymethoxy)-2,3-dichlorobenzoyl)-2,5-diethyl-3,4-dihydro-2H-pyran-6-yl]-2,3-dichlorophenoxy}acetic acid) |
25355-92-4 |
|
| 2932996560 |
|
|
|
| USP-1257007 |
Ethambutol Hydrochloride (200 mg) |
1070-11-7 |
|
| 2922199695 |
|
|
|
| USP-1257018 |
Ethambutol Related Compound A (15 mg) ((2R,2’S)-2,2′-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol)dihydrochloride) |
32454-69-6 |
|
| 2922199695 |
|
|
|
| USP-1257029 |
Ethambutol Related Compound B (15 mg) (((2R,2’R)-2,2′-[Ethane-1,2-diylbis(azanediyl)]dibutan-1-ol) dihydrochloride) |
134566-79-3 |
|
| 2922199695 |
|
|
|
| USP-1260001 |
Ethinyl Estradiol (150 mg) |
57-63-6 |
UN3077 |
| USP-1260012 |
Ethinyl Estradiol Related Compound A (20 mg) (19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol-6-one) |
38002-18-5 |
|
| 2937230000 |
|
|
|
| USP-1260023 |
Ethinyl Estradiol Related Compound B (20 mg) (19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol monohydrate) |
N/A |
|
| 2937230000 |
|
|
|
| USP-1261004 |
Ethionamide (200 mg) |
536-33-4 |
|
| 2933399095 |
|
|
|
| USP-1261117 |
Ethisterone (50 mg) |
434-03-7 |
|
| 2937230000 |
|
|
|
| USP-1262801 |
Ethopabate (125 mg) |
1959/6/3 |
|
| 2924296000 |
|
|
|
| USP-1262823 |
Ethopabate Related Compound A (25 mg) (Methyl-4-acetamido-2-hydroxybenzoate) |
N/A |
|
| 2924296000 |
|
|
|
| USP-1264002 |
Ethosuximide (500 mg) |
77-67-8 |
|
| 2925190100 |
|
|
|
| USP-1264013 |
Ethosuximide Related Compound A (50 mg) (2-Ethyl-2-methylsuccinic acid) |
631-31-2 |
|
| 2917197055 |
|
|
|
| USP-1264501 |
Ethotoin (500 mg) |
86-35-1 |
|
| 2933210000 |
|
|
|
| USP-1265300 |
Ethyl 4-nitrobenzoate (40 mg) |
99-77-4 |
|
| 2916399000 |
|
|
|
| USP-1265504 |
Ethylcellulose (1 g) |
9004-57-3 |
|
| 3912390000 |
|
|
|
| USP-1265537 |
Ethylhexyl Triazone (200 mg) |
88122-99-0 |
|
| 2933690000 |
|
|
|
| USP-1265548 |
Ethylhexyl Triazone Related Compound A (20 mg) (2-ethylhexyl 4-aminobenzoate) |
26218-04-2 |
|
| 2922493800 |
|
|
|
| USP-1265559 |
Ethylhexyl Triazone Related Compound B (20 mg) (4-[(4,6-Bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) |
N/A |
|
| 2933690000 |
|
|
|
| USP-1265560 |
Ethylhexyl Triazone Related Compound C (20 mg) (Bis(2-ethylhexyl) 4,4′-[(6-{[4-(ethoxycarbonyl)phenyl]amino}-1,3,5-triazine-2,4-diyl)bis(azanediyl)]dibenzoate) |
N/A |
|
| 2933690000 |
|
|
|
| USP-1265592 |
Ethylene Glycol and Vinyl Alcohol Graft Copolymer (1 g) |
121786-16-1 |
|
| 3905915000 |
|
|
|
| USP-1265800 |
Ethyl Lauroyl Arginate (200 mg) |
60372-77-2 |
UN3077 |
| USP-1266008 |
Ethyl Maltol (1 g) |
4940/11/8 |
|
| 2932999000 |
|
|
|
| USP-1266824 |
Etravirine (100 mg) |
269055-15-4 |
|
| 2933595960 |
|
|
|
| USP-1266835 |
Etravirine System Suitability Mixture (15 mg) |
NA |
|
| 3822190000 |
|
|
|
| USP-1266868 |
Ethyl Palmitate (500 mg) |
628-97-7 |
|
| 2915700100 |
|
|
|
| USP-1267000 |
Ethylparaben (200 mg) |
120-47-8 |
|
| 2918290000 |
|
|
|
| USP-1267102 |
Ethyl Stearate (100 mg) |
111-61-5 |
UN3077 |
| USP-1267500 |
Ethyl Vanillin (200 mg) |
121-32-4 |
|
| 2912420000 |
|
|
|
| USP-1268003 |
Ethynodiol Diacetate (200 mg) |
297-76-7 |
|
| 2937230000 |
|
|
|
| USP-1268502 |
Etidronate Disodium (200 mg) |
7414-83-7 |
|
| 2931450000 |
|
|
|
| USP-1268513 |
Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate) |
13517-23-2 |
|
| 2835100000 |
|
|
|
| USP-1268604 |
Etidronic Acid Monohydrate (1 g) |
25211-86-3 |
|
| 2931490000 |
|
|
|
| USP-1268706 |
Etodolac (400 mg) |
41340-25-4 |
UN2811 |
| USP-1268728 |
Etodolac Related Compound A (25 mg) ((+/-)-8-Ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid) |
109518-50-5 |
|
| 2934990005 |
|
|
|
| USP-1268750 |
Etomidate (200 mg) |
33125-97-2 |
UN3077 |
| USP-1268772 |
Metomidate Hydrochloride (50 mg) (Methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride) |
35944-74-2 |
UN2811 |
| USP-1268783 |
Etonogestrel (100 mg) |
54048-10-1 |
|
| 2937230000 |
|
|
|
| USP-1268794 |
Etonogestrel Related Compound A (10 mg) (13Beta-Ethyl-11-methylenegon-4-ene-3,17-dione) |
54024-17-8 |
|
| 2914299000 |
|
|
|
| USP-1268808 |
Etoposide (300 mg) |
33419-42-0 |
|
| 2938900000 |
|
|
|
| USP-1268819 |
Etoposide Phosphate (200 mg) |
117091-64-2 |
UN1325 |
| USP-1268839 |
Etonogestrel Related Compound B (10 mg) (13-Ethyl-6Beta,17Beta-dihydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one) |
215252-94-1 |
|
| 2914409000 |
|
|
|
| USP-1268841 |
Etonogestrel Related Compound C (10 mg) (13-Ethyl-17Beta-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3,6-dione) |
N/A |
|
| 2914409000 |
|
|
|
| USP-1268852 |
Etoposide Resolution Mixture (10 mg) |
N/A |
|
| 2938900000 |
|
|
|
| USP-1268892 |
Etodolac Peak Identification Mixture (15 mg) |
MIXTURE |
UN2811 |
| USP-1268943 |
Etonogestrel Related Compound D (10 mg) (17Beta-Hydroxy-11-methylene-19-nor-17alpha-pregn-4-en-20-yn-3-one) |
54024-10-1 |
|
| 2914409000 |
|
|
|
| USP-1268976 |
Everolimus (300 mg) |
159351-69-6 |
UN3077 |
| USP-1268987 |
Everolimus System Suitability Mixture (25 mg) (This is a mixture of everolimus, everolimus oxepane isomer and 9-O-hydroxyethyl sirolimus) |
N/A |
UN3077 |
| USP-1268998 |
[Glu13]-Exenatide (1 mg) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1269009 |
[Met(O)14]-Exenatide (1 mg) |
1678417-38-3 |
|
| 2933998350 |
|
|
|
| USP-1269028 |
Ezetimibe (250 mg) |
163222-33-1 |
|
| 2933790002 |
|
|
|
| USP-1269039 |
Ezetimibe System Suitability Mixture (20 mg) |
Mixture |
|
| 3822190000 |
|
|
|
| USP-1269045 |
[N-Acetyl-His1]-Exenatide (1 mg) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1269050 |
Exemestane (150 mg) |
107868-30-4 |
|
| 2937290000 |
|
|
|
| USP-1269061 |
Exemestane Related Compound A (15 mg) (6-Methyleneandrosta-4-ene-3,17-dione) |
19457-55-7 |
|
| 2914299000 |
|
|
|
| USP-1269072 |
Exemestane Related Compound B (15 mg) (6-hydroxymethylandrostra-1,4-diene-3,17-dione) |
184972-09-6 |
|
| 2914299000 |
|
|
|
| USP-1269094 |
Exemestane System Suitability Mixture (25 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1269105 |
Exenatide (2.73 mg) |
141758-74-9 |
|
| 2933290000 |
|
|
|
| USP-1269130 |
Famciclovir Related Compound E (25 mg) (2-aminopurine) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1269141 |
Famciclovir Related Compound F (25 mg) (2-Amino-6-chloropurine) |
10310-21-1 |
|
| 2933997500 |
|
|
|
| USP-1269152 |
Famciclovir (200 mg) |
104227-87-4 |
|
| 2933595960 |
|
|
|
| USP-1269163 |
Famciclovir System Suitability Mixture (20 mg) (Mixture of Famciclovir, Propionyl famciclovir and 6-Chloro famciclovir) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1359925 |
Levocarnitine Related Compound A (100 mg) (2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-, chloride) |
6538-82-5 |
|
| 2923900100 |
|
|
|
| USP-1359958 |
Levocetirizine Amide (75 mg) |
909779-33-5 |
|
| 2933595960 |
|
|
|
| USP-1359969 |
Levocetirizine Dihydrochloride (200 mg) |
130018-87-0 |
|
| 2933595960 |
|
|
|
| USP-1361009 |
Levodopa (200 mg) |
59-92-7 |
|
| 2922504500 |
|
|
|
| USP-1361010 |
Levodopa Related Compound A (50 mg) (3-(2,4,5-Trihydroxyphenyl)-L-alanine) (需冷链运输) |
27244-64-0 |
|
| 2922504500 |
|
|
|
| USP-1362103 |
Levofloxacin (200 mg) |
138199-71-0 |
|
| 2934990005 |
|
|
|
| USP-1362114 |
Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
117707-40-1 |
|
| 2934990005 |
|
|
|
| USP-1362125 |
Levofloxacin Related Compound B (35 mg) ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
100986-89-8 |
|
| 2934990005 |
|
|
|
| USP-1362136 |
Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate) |
177472-30-9 |
|
| 2934990005 |
|
|
|
| USP-1362158 |
Levofloxacin Related Compound E (25 mg) ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride) |
1346603-62-0 |
|
| 2934990005 |
|
|
|
| USP-1362169 |
Levofloxacin Related Compound F (25 mg) ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
117620-85-6 |
|
| 2934990005 |
|
|
|
| USP-1362500 |
Levonordefrin (200 mg) |
829-74-3 |
UN2811 |
| USP-1362602 |
Levonorgestrel (125 mg) |
797-63-7 |
|
| 2937230000 |
|
|
|
| USP-1365000 |
Levothyroxine (500 mg) |
51-48-9 |
|
| 2937903000 |
|
|
|
| USP-1365065 |
Levothyroxine Sodium (50 mg) |
25416-65-3 (hydrate) |
|
| 2937903000 |
|
|
|
| USP-1366002 |
Lidocaine (250 mg) |
137-58-6 |
|
| 2924296000 |
|
|
|
| USP-1366013 |
Lidocaine Hydrochloride (150 mg) |
6108-05-0 |
UN2811 |
| USP-1366080 |
Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide) |
1131-01-7 |
|
| 2924296000 |
|
|
|
| USP-1366534 |
Linarin (50 mg) |
480-36-4 |
|
| 2938900000 |
|
|
|
| USP-1367005 |
Lincomycin Hydrochloride (200 mg) |
7179-49-9 |
|
| 2941906000 |
|
|
|
| USP-1367504 |
Lindane (200 mg) |
58-89-9 |
UN2761 |
| USP-1367515 |
Lindane Related Compound A (25 mg) ((1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-Hexachlorocyclohexane) |
319-84-6 |
UN2811 |
| USP-1367561 |
Linezolid (200 mg) |
165800-03-3 |
|
| 2934990005 |
|
|
|
| USP-1367570 |
Linezolid Related Compound A (20 mg) ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) |
168828-84-0 |
|
| 2934990005 |
|
|
|
| USP-1367581 |
Linezolid Related Compound B (20 mg) ((S)-N-{[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide) |
216868-57-4 |
|
| 2934990005 |
|
|
|
| USP-1367592 |
Linezolid Related Compound C (20 mg) ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) |
168828-90-8 |
|
| 2934990005 |
|
|
|
| USP-1367606 |
Linezolid Related Compound D (20 mg) ((R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl methanesulfonate) |
174649-09-3 |
|
| 2934990005 |
|
|
|
| USP-1367639 |
Linezolid R-Isomer (20 mg) (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide) |
872992-20-6 |
|
| 2934990005 |
|
|
|
| USP-1368008 |
Liothyronine (250 mg) |
6893/2/3 |
|
| 2937903000 |
|
|
|
| USP-1368201 |
Alpha Lipoic Acid (500 mg) |
1077-28-7 |
|
| 2934990005 |
|
|
|
| USP-1368609 |
Lisinopril (300 mg) |
83915-83-7 |
|
| 2933995300 |
|
|
|
| USP-1368610 |
Lisinopril Related Compound A (250 mg) ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-alpha]pyrazin-2(1H)-yl}-4-phenylbutanoic acid) |
328385-86-0 |
|
| 2933998350 |
|
|
|
| USP-1369000 |
Lithium Carbonate (300 mg) |
554-13-2 |
UN3077 |
| USP-1369055 |
Lithol Rubine BK (100 mg) (2-Naphthalenecarboxylic acid, 3-hydroxy-4-[(E)-2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1)) |
5281/4/9 |
|
| 3204170000 |
|
|
|
| USP-1369419 |
Lomustine (200 mg) |
13010-47-4 |
UN2811 |
| USP-1369431 |
Lomustine Related Compound B (25 mg) (1-(2-Chloroethyl)-3-cyclohexylurea) |
2008/11/7 |
|
| 2929909000 |
|
|
|
| USP-1369442 |
Lomustine Related Compound C (25 mg) (1,3-Dicyclohexylurea) |
2387-23-7 |
|
| 2924210000 |
|
|
|
| USP-1369453 |
Lomustine Related Compound D (25 mg) (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) |
54749-91-6 |
|
| 2929909000 |
|
|
|
| USP-1369689 |
Lonicera Japonica Flower Dry Extract (500 mg) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1369703 |
Lonicera Macranthoides Flower Dry Extract (500 mg) (Mixture, with identified compendial components Dipsacoside B, Macranthoidin A and Macranthoidin B) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1370000 |
Loperamide Hydrochloride (200 mg) |
34552-83-5 |
UN2811 |
| USP-1370065 |
Loperamide Related Compound F (25 mg) (1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine 1-oxide hydrate) |
106900-12-3 |
UN2811 |
| USP-1370101 |
Lopinavir (350 mg) |
192725-17-0 |
|
| 2933595960 |
|
|
|
| USP-1370156 |
Lopinavir System Suitability Mixture (10 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1370269 |
Loratadine Related Compound C (15 mg) (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one) |
31251-41-9 |
|
| 2933998350 |
|
|
|
| USP-1370270 |
Loratadine (200 mg) |
79794-75-5 |
UN3077 |
| USP-1370280 |
Loratadine Related Compound A (15 mg) (8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine) |
100643-71-8 |
|
| 2933399095 |
|
|
|
| USP-1370291 |
Loratadine Related Compound B (15 mg) (8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1370327 |
Lorazepam Related Compound A (25 mg) (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one) |
2848-96-6 |
|
| 2933997500 |
|
|
|
| USP-1370338 |
Lorazepam Related Compound B (25 mg) (2-Amino-2′,5-dichlorobenzophenone) |
2958-36-3 |
|
| 2922390000 |
|
|
|
| USP-1370349 |
Lorazepam Related Compound C (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde) |
93955-15-8 |
|
| 2933997500 |
|
|
|
| USP-1370350 |
Lorazepam Related Compound D (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid) |
54643-79-7 |
|
| 2933997500 |
|
|
|
| USP-1509019 |
Powdered Black Pepper Extract (1 g) |
84929-41-9 |
|
| 2938900000 |
|
|
|
| USP-1510051 |
Pepsin for Assay (5 x 1 g) (需冷链运输) |
9001-75-6 |
|
| 3507907000 |
|
|
|
| USP-1510845 |
Pergolide Mesylate (200 mg) |
66104-23-2 |
UN1544 |
| USP-1510867 |
Pergolide Sulfoxide (50 mg) |
72822-01-6 |
UN1544 |
| USP-1510889 |
Perindopril Erbumine (100 mg) |
107133-36-8 |
|
| 2933999552 |
|
|
|
| USP-1510890 |
Perindopril Related Compound A (20 mg) ((2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid) |
80875-98-5 |
|
| 2933999552 |
|
|
|
| USP-1510903 |
Perindopril Related Compound B (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-carboxybutylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid monohydrate) |
1418095-48-3 |
|
| 2933999552 |
|
|
|
| USP-1510914 |
Perindopril Related Compound C (20 mg) ((S)-2-[(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]pentanoic acid) |
129970-99-6 |
|
| 2933999552 |
|
|
|
| USP-1510925 |
Perindopril Related Compound D (25 mg) ((S)-2-{(3S,5aS,9aS,10aR)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoic acid) |
130061-28-8 |
|
| 2933999552 |
|
|
|
| USP-1510936 |
Perindopril Related Compound E (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine) |
N/A |
|
| 2933999552 |
|
|
|
| USP-1510947 |
Perindopril Related Compound F (10 mg) ((S)-ethyl 2-{(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoate) |
129970-98-5 |
|
| 2933999552 |
|
|
|
| USP-1510970 |
Perindopril Related Compound I (20 mg) (2-Methylpropan-2-amine (2S,3aS,7aS)-1-{(S)-2-[(R)-1-ethoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylate) |
N/A |
|
| 2933999552 |
|
|
|
| USP-1510999 |
Perindopril Related Compound K (10 mg) ((3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione) |
2165676-00-4 |
|
| 2933999552 |
|
|
|
| USP-1511000 |
Perphenazine (200 mg) |
58-39-9 |
UN2811 |
| USP-1511021 |
Perphenazine Related Compound B (15 mg) (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol) |
3533-97-9 |
|
| 2934305050 |
|
|
|
| USP-1511203 |
Perphenazine Sulfoxide (25 mg) |
10078-25-8 |
|
| 2934305050 |
|
|
|
| USP-1513005 |
Phenacetin (500 mg) |
62-44-2 |
|
| 2924296000 |
|
|
|
| USP-1514008 |
Phenacetin Melting Point Standard (1 g) (Approximately 135 degrees) |
62-44-2 |
|
| 2924296000 |
|
|
|
| USP-1515000 |
Phenazopyridine Hydrochloride (200 mg) |
136-40-3 |
|
| 2933399095 |
|
|
|
| USP-1517006 |
Phenelzine Sulfate (200 mg) |
156-51-4 |
UN2811 |
| USP-1522301 |
Pheniramine Maleate (150 mg) |
132-20-7 |
|
| 2933399095 |
|
|
|
| USP-1524012 |
Phenobarbital Related Compound A (30 mg) (5-Ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one) |
69125-70-8 |
|
| 2933599550 |
|
|
|
| USP-1524023 |
Phenobarbital Related Compound B (30 mg) (5-Ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione) |
58042-96-9 |
|
| 2933599550 |
|
|
|
| USP-1524806 |
Phenol (500 mg) |
108-95-2 |
UN1671 |
| USP-1525707 |
Phenothiazine (500 mg) |
92-84-2 |
|
| 2934305050 |
|
|
|
| USP-1526007 |
Phenoxybenzamine Hydrochloride (250 mg) |
63-92-3 |
UN3261 |
| USP-1528512 |
Phentermine Related Compound A (30 mg) (N-(2-Methyl-1-phenylpropan-2-yl)formamide) |
52117-13-2 |
|
| 2924296000 |
|
|
|
| USP-1529016 |
Phentolamine Related Compound A (25 mg) (N-(2-Aminoethyl)-2-[(3-hydroxyphenyl)(4-tolyl)amino]acetamide) |
N/A |
|
| 2924296000 |
|
|
|
| USP-1529071 |
Phentolamine Keto Analog (25 mg) (N-(3-Hydroxyphenyl)-N-(4-tolyl)-4,5-dihydro-1H-imidazole-2-carboxamide) |
N/A |
|
| 2933290000 |
|
|
|
| USP-1530004 |
Phentolamine Mesylate (200 mg) |
65-28-1 |
|
| 2933290000 |
|
|
|
| USP-1530503 |
L-Phenylalanine (200 mg) |
63-91-2 |
|
| 2922491000 |
|
|
|
| USP-1530809 |
Ensulizole (200 mg) (2-phenylbenzimidazole-5-sulfonic acid) |
27503-81-7 |
|
| 2933998350 |
|
|
|
| USP-1531007 |
Phenylbutazone (250 mg) |
50-33-9 |
UN2811 |
| USP-1532950 |
Phenylephrine Bitartrate (25 mg) |
17162-39-9 |
|
| 2922504500 |
|
|
|
| USP-1533002 |
Phenylephrine Hydrochloride (200 mg) |
61-76-7 |
|
| 2922504500 |
|
|
|
| USP-1533024 |
Phenylephrine Related Compound C (30 mg) (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride) |
94240-17-2 |
|
| 2922504500 |
|
|
|
| USP-1554909 |
Prednicarbate (200 mg) |
73771-04-7 |
|
| 2937290000 |
|
|
|
| USP-1554910 |
Prednicarbate Related Compound A (20 mg) (1,2-dihydroprednicarbate) |
671225-26-6 |
|
| 2937290000 |
|
|
|
| USP-1554920 |
Prednicarbate Related Compound B (20 mg) (prednisolone-17-ethylcarbonate) |
104286-02-4 |
|
| 2937290000 |
|
|
|
| USP-1554931 |
Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate) |
5740-62-5 |
|
| 2937290000 |
|
|
|
| USP-1555005 |
Prednisolone (200 mg) |
50-24-8 |
|
| 2937210000 |
|
|
|
| USP-1556008 |
Prednisolone Acetate (200 mg) |
52-21-1 |
|
| 2937290000 |
|
|
|
| USP-1556507 |
Prednisolone Hemisuccinate (125 mg) |
2920-86-7 |
|
| 2937290000 |
|
|
|
| USP-1557000 |
Prednisolone Sodium Phosphate (500 mg) |
125-02-0 |
|
| 2937290000 |
|
|
|
